Network Pharmacology Analysis of Shared AD Targets

Exploratory Score: 0.850 Price: $0.50 Alzheimer's disease Computational network analysis Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting N/A in Computational network analysis. Primary outcome: Identification of shared molecular targets

Description

A computational network pharmacology approach was employed to identify shared molecular targets between curcumin, Glycyrrhiza glabra, and Alzheimer's disease pathways. This bioinformatics analysis revealed 40 common targets associated with AD pathogenesis that could be modulated by both compounds. The network analysis provided insights into the molecular mechanisms underlying the synergistic effects observed in the animal studies, with particular enrichment in NF-κB and IL-17 signaling pathways. This computational prediction was subsequently validated through experimental verification in the mouse model, demonstrating the reliability of the network pharmacology approach for understanding multi-compound therapeutic mechanisms.

TARGET GENE
N/A
MODEL SYSTEM
Computational network analysis
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
NF-κB signaling, IL-17 signaling
SOURCE
extracted_from_pmid_41920384
PRIMARY OUTCOME
Identification of shared molecular targets

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

Agitation in Alzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAPP Mutations in Alzheimer's DiseasediseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseInvestment Landscape: Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseasePSEN1 Mutations in Alzheimer's DiseasediseasePSEN2 Mutations in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseaseTREM2 Variants in Alzheimer's Diseasedisease

Protocol

Network pharmacology analysis to identify overlapping targets between curcumin, G. glabra, and AD-related pathways, followed by pathway enrichment analysis and experimental validation

Expected Outcomes

Discovery of common therapeutic targets and pathways for synergistic drug action

Success Criteria

Identification of significant target overlap and pathway enrichment, validated by experimental results

Related Hypotheses (5)

TREM2-mediated microglial tau clearance enhancement0.594
LRP1-Dependent Tau Uptake Disruption0.576
VCP-Mediated Autophagy Enhancement0.571
Extracellular Vesicle Biogenesis Modulation0.558
Perinatal Hypoxia-Primed Microglia Targeting0.548

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.